… of heart failure progression has recently become universally recognized. According to this
tenet, heart failure … diagnostic approaches and at the same time serve as therapeutic targets. …

… Puma, therefore, represents a potential therapeutic target to attenuate cell death in a variety
of different conditions, including ischemic heart disease, heart failure or during cell therapy …

… Therapeutic targets in HCM are likely to be most effective when directed to the molecular …
heart failure and hypertrophic cardiomyopathy and for its use in systolic heart failure in …

… Ischemic heart disease is a form of congestive heart failure that is caused by insufficient …
therapeutic target for cardiac remodeling is miR-208. miR-208 is solely expressed in the heart as …

… Regulation of myocardial MMP expression and activity may be an important therapeutic
target for controlling myocardial matrix remodeling in the setting of developing heart failure. …

… heart failure is the end stage of cardiac diseases. With a high prevalence and a high mortality
rate worldwide, chronic heart failure … novel insights for future therapeutic targets. On the …

… to heart failure, we extended the TAC stress imposed on Pak1 f/f and Pak1 cko mice to 5
weeks. Indeed, Pak1 cko mice showed characteristics of heart failure … confirmed heart failure, …

… therapeutic targets for several cardiovascular disorders. In this review we provides an overview
of the effects of several CVD; including heart failure, … miRNA as therapeutic targets is also …

… to therapy. Several miRNAs have been related to important mechanisms leading to heart
failure… An increasing number of miRNAs and miRNA targets have been reported in heart failure …

… with moderate or severe heart failure, those with depressed … of death due to progressive heart
failure than conventional clinical … to high risk patients with heart failure or MI. Low HRV has …